A recent study suggests that a biomarker associated with Alzheimer's disease may help identify women more vulnerable to developing dementia when using certain hormone therapies. The research, which analyzed blood samples from nearly 2,800 women, indicates that the relationship between the biomarker and the risk of dementia varies depending on the type of hormone therapy employed. Alzheimer's biomarker and hormone therapy The biomarker in questio…